Enhancement of neutrophil function by granulocyte-macrophage colony-stimulating factor involves recruitment of a less responsive subpopulation.

Human granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances numerous functions of mature neutrophils (PMN) including phagocytosis, superoxide responses to chemotaxins, antibody-dependent cellular cytotoxicity, and expression of complement receptors. A central question concerns whether the mechanism of enhancement involves quantitative increases in the response of all cells v subpopulation recruitment. The effects of GM-CSF on individual cell light scatter changes, membrane potential, and oxidant responses induced by the chemoattractant N-formyl-methionyl-leucyl-phenylalanine (FMLP) were assessed by flow cytometry and by scoring individual cells for nitroblue tetrazolium dye (NBT) reduction. GM-CSF produced a dose- and time-dependent shift in forward light scatter that was very similar in character to that seen with FMLP or leukotriene B4 stimulation. Although not capable of depolarizing the cells directly, GM-CSF primed PMNs for enhanced membrane potential responses to FMLP by significantly increasing the proportion of depolarizing cells when compared with diluent-treated controls after a 60-minute incubation at 37 degrees C (79.4% +/- 3.4% v 29.5% +/- 4.7% GM-CSF v diluent, mean +/- SE, P less than .005, n = 11). Subpopulation recruitment by GM-CSF treatment was also demonstrated by the FMLP-elicited NBT test. Taken together, these results indicate that GM-CSF can modulate the function of mature PMN by enhancing the proportion of responsive cells.

[1]  M. Namiki,et al.  HUMAN GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR , 1996 .

[2]  D. Golde,et al.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. , 1987, Blood.

[3]  D. Golde,et al.  Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. , 1986, Journal of immunology.

[4]  J. Gamble,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.

[5]  M. P. Fletcher,et al.  PMN heterogeneity: long-term stability of fluorescent membrane potential responses to the chemoattractant N-formyl-methionyl-leucyl-phenylalanine in healthy adults and correlation with respiratory burst activity. , 1986, Blood.

[6]  E. Simons,et al.  Simultaneous measurement of stimulus-induced changes in cytoplasmic Ca2+ and in membrane potential of human neutrophils. , 1986, The Journal of biological chemistry.

[7]  M. P. Fletcher Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment. , 1986, Journal of immunology.

[8]  M. Seeds,et al.  Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. , 1986, Journal of immunology.

[9]  V. Price,et al.  Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. , 1986, Science.

[10]  Clark,et al.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. , 1986, Blood.

[11]  D. Golde,et al.  Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. , 1986, Blood.

[12]  D. Metcalf Granulocyte-macrophage colony-stimulating factors , 1985, Cell.

[13]  B. Seligmann,et al.  An antibody binding to human neutrophils demonstrates antigenic heterogeneity detected early in myeloid maturation which correlates with functional heterogeneity of mature neutrophils. , 1985, Journal of immunology.

[14]  E. Brown,et al.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.

[15]  A. Burgess,et al.  Specific binding of radioiodinated granulocyte‐macrophage colony‐stimulating factor to hemopoietic cells. , 1985, EMBO Journal.

[16]  B. Seligmann,et al.  Monitoring Human Neutrophil Granule Secretion by Flow Cytometry: Secretion and Membrane Potential Changes Assessed by Light Scatter and a Fluorescent Probe of Membrane Potential , 1985, Journal of leukocyte biology.

[17]  D. Golde,et al.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator , 1985, Nature.

[18]  D. Golde,et al.  Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.

[19]  L. Mcphail,et al.  Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme , 1984, The Journal of experimental medicine.

[20]  M. Vadas,et al.  Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. , 1983, Journal of immunology.

[21]  M. Vadas,et al.  Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. , 1983, Journal of immunology.

[22]  L. Clement,et al.  Identification of neutrophil subpopulations with monoclonal antibodies. , 1983, Blood.

[23]  R. Graziano,et al.  Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. Seligmann,et al.  Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential. , 1981, The Journal of clinical investigation.

[25]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.